Global Primary Biliary Cholangitis Therapeutics Market Size, Status and Forecast 2021-2027

Published Date : 07-04-2021
Pages : 92
Report Id : 19168
Categories : Healthcare

Primary biliary cholangitis (PBC), previously known as primary biliary cirrhosis, is an autoimmune disease of the liver.
There is a dire need for curative therapy for primary biliary cholangitis across the world. This is because of the recurring nature of the disease. Currently, the only cure for the condition is a liver transplant. This method of treatment makes it difficult for patients to lead a normal life even with post-surgery treatment. This has resulted in research on stem cell transplantation to replace destroyed cells in the bile duct.
In 2020, the global Primary Biliary Cholangitis Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2027, with a CAGR of xx% during 2021-2027.

This report focuses on the global Primary Biliary Cholangitis Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Primary Biliary Cholangitis Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Abbott Laboratories
Allergan Plc
Eli Lilly and Co.
Intercept Pharmaceuticals Inc.
Takeda Pharmaceutical Co. Ltd.
...

Market segment by Type, the product can be split into
OCALIVA
Ursodiol
Others

Market segment by Application, split into
Hospital
Private Clinic
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Primary Biliary Cholangitis Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Primary Biliary Cholangitis Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Primary Biliary Cholangitis Therapeutics are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Primary Biliary Cholangitis Therapeutics Market Size Growth Rate by Type (2016-2027)
1.4.2 OCALIVA
1.4.3 Ursodiol
1.4.4 Others
1.5 Market by Application
1.5.1 Global Primary Biliary Cholangitis Therapeutics Market Share by Application (2021-2027)
1.5.2 Hospital
1.5.3 Private Clinic
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Primary Biliary Cholangitis Therapeutics Market Size
2.2 Primary Biliary Cholangitis Therapeutics Growth Trends by Regions
2.2.1 Primary Biliary Cholangitis Therapeutics Market Size by Regions (2021-2027)
2.2.2 Primary Biliary Cholangitis Therapeutics Market Share by Regions (2016-2021)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter�s Five Forces Analysis

3 Market Share by Key Players
3.1 Primary Biliary Cholangitis Therapeutics Market Size by by Players
3.1.1 Global Primary Biliary Cholangitis Therapeutics Revenue by by Players (2016-2021)
3.1.2 Global Primary Biliary Cholangitis Therapeutics Revenue Market Share by by Players (2016-2021)
3.1.3 Global Primary Biliary Cholangitis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Primary Biliary Cholangitis Therapeutics Key Players Head office and Area Served
3.3 Key Players Primary Biliary Cholangitis Therapeutics Product/Solution/Service
3.4 Date of Enter into Primary Biliary Cholangitis Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Primary Biliary Cholangitis Therapeutics Market Size by Type (2016-2021)
4.2 Global Primary Biliary Cholangitis Therapeutics Market Size by Application (2016-2021)

5 North America
5.1 North America Primary Biliary Cholangitis Therapeutics Market Size (2016-2021)
5.2 Primary Biliary Cholangitis Therapeutics Key Players in North America
5.3 North America Primary Biliary Cholangitis Therapeutics Market Size by Type
5.4 North America Primary Biliary Cholangitis Therapeutics Market Size by Application

6 Europe
6.1 Europe Primary Biliary Cholangitis Therapeutics Market Size (2016-2021)
6.2 Primary Biliary Cholangitis Therapeutics Key Players in Europe
6.3 Europe Primary Biliary Cholangitis Therapeutics Market Size by Type
6.4 Europe Primary Biliary Cholangitis Therapeutics Market Size by Application

7 China
7.1 China Primary Biliary Cholangitis Therapeutics Market Size (2016-2021)
7.2 Primary Biliary Cholangitis Therapeutics Key Players in China
7.3 China Primary Biliary Cholangitis Therapeutics Market Size by Type
7.4 China Primary Biliary Cholangitis Therapeutics Market Size by Application

8 Japan
8.1 Japan Primary Biliary Cholangitis Therapeutics Market Size (2016-2021)
8.2 Primary Biliary Cholangitis Therapeutics Key Players in Japan
8.3 Japan Primary Biliary Cholangitis Therapeutics Market Size by Type
8.4 Japan Primary Biliary Cholangitis Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Primary Biliary Cholangitis Therapeutics Market Size (2016-2021)
9.2 Primary Biliary Cholangitis Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Primary Biliary Cholangitis Therapeutics Market Size by Type
9.4 Southeast Asia Primary Biliary Cholangitis Therapeutics Market Size by Application

10 India
10.1 India Primary Biliary Cholangitis Therapeutics Market Size (2016-2021)
10.2 Primary Biliary Cholangitis Therapeutics Key Players in India
10.3 India Primary Biliary Cholangitis Therapeutics Market Size by Type
10.4 India Primary Biliary Cholangitis Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Primary Biliary Cholangitis Therapeutics Market Size (2016-2021)
11.2 Primary Biliary Cholangitis Therapeutics Key Players in Central & South America
11.3 Central & South America Primary Biliary Cholangitis Therapeutics Market Size by Type
11.4 Central & South America Primary Biliary Cholangitis Therapeutics Market Size by Application

12 International Players Profiles
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Company Details
12.1.2 Company Description and Business Overview
12.1.3 Primary Biliary Cholangitis Therapeutics Introduction
12.1.4 Abbott Laboratories Revenue in Primary Biliary Cholangitis Therapeutics Business (2016-2021))
12.1.5 Abbott Laboratories Recent Development
12.2 Allergan Plc
12.2.1 Allergan Plc Company Details
12.2.2 Company Description and Business Overview
12.2.3 Primary Biliary Cholangitis Therapeutics Introduction
12.2.4 Allergan Plc Revenue in Primary Biliary Cholangitis Therapeutics Business (2016-2021)
12.2.5 Allergan Plc Recent Development
12.3 Eli Lilly and Co.
12.3.1 Eli Lilly and Co. Company Details
12.3.2 Company Description and Business Overview
12.3.3 Primary Biliary Cholangitis Therapeutics Introduction
12.3.4 Eli Lilly and Co. Revenue in Primary Biliary Cholangitis Therapeutics Business (2016-2021)
12.3.5 Eli Lilly and Co. Recent Development
12.4 Intercept Pharmaceuticals Inc.
12.4.1 Intercept Pharmaceuticals Inc. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Primary Biliary Cholangitis Therapeutics Introduction
12.4.4 Intercept Pharmaceuticals Inc. Revenue in Primary Biliary Cholangitis Therapeutics Business (2016-2021)
12.4.5 Intercept Pharmaceuticals Inc. Recent Development
12.5 Takeda Pharmaceutical Co. Ltd.
12.5.1 Takeda Pharmaceutical Co. Ltd. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Primary Biliary Cholangitis Therapeutics Introduction
12.5.4 Takeda Pharmaceutical Co. Ltd. Revenue in Primary Biliary Cholangitis Therapeutics Business (2016-2021)
12.5.5 Takeda Pharmaceutical Co. Ltd. Recent Development

13 Market Forecast 2021-2027
13.1 Market Size Forecast by Product (2021-2027)
13.2 Market Size Forecast by Application (2021-2027)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Primary Biliary Cholangitis Therapeutics Key Market Segments
Table Key Players Primary Biliary Cholangitis Therapeutics Covered
Table Global Primary Biliary Cholangitis Therapeutics Market Size Growth Rate by Type 2020-2027 (Million US$)
Figuer OCALIVA Figures
Table Key Players of OCALIVA
Figuer Ursodiol Figures
Table Key Players of Ursodiol
Figuer Others Figures
Table Key Players of Others
Table Global Primary Biliary Cholangitis Therapeutics Market Size Growth by Application 2021-2027 (Million US$)
Figure Global Primary Biliary Cholangitis Therapeutics Market Share by Application in 2020 & 2027
Figure Hospital Case Studies
Figure Private Clinic Case Studies
Figure Other Case Studies
Figure Primary Biliary Cholangitis Therapeutics Report Years Considered
Figure Global Primary Biliary Cholangitis Therapeutics Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Primary Biliary Cholangitis Therapeutics Market Size by Regions 2021-2027 (Million US$)
Table Global Primary Biliary Cholangitis Therapeutics Market Size by Regions 2021-2027 (Million US$)
Table Global Primary Biliary Cholangitis Therapeutics Market Share by Regions 2016-2021
Figure Global Primary Biliary Cholangitis Therapeutics Market Share by Regions 2016-2021
Figure Global Primary Biliary Cholangitis Therapeutics Market Share by Regions in 2020
Table Market Top Trends
Table Key Drivers: Impact Analysis (2021-2027)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Primary Biliary Cholangitis Therapeutics Revenue by by Players (2016-2021) (Million US$)
Table Global Primary Biliary Cholangitis Therapeutics Market Share by by Players (2016-2021)
Figure Global Primary Biliary Cholangitis Therapeutics Market Share by by Players in 2020
Table Global Primary Biliary Cholangitis Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Primary Biliary Cholangitis Therapeutics Product/Solution/Service
Table Date of Enter into Primary Biliary Cholangitis Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Primary Biliary Cholangitis Therapeutics Market Size by Type (2016-2021) (Million US$)
Table Global Primary Biliary Cholangitis Therapeutics Market Size Share by Type (2016-2021)
Figure Global Primary Biliary Cholangitis Therapeutics Market Size Market Share by Type (2016-2021)
Table Global Primary Biliary Cholangitis Therapeutics Market Size by Application (2016-2021) (Million US$)
Table Global Primary Biliary Cholangitis Therapeutics Market Size Share by Application (2016-2021)
Figure Global Primary Biliary Cholangitis Therapeutics Market Size Market Share by Application (2016-2021)
Figure Global Primary Biliary Cholangitis Therapeutics Revenue Market Share by Application in 2020
Figure North America Primary Biliary Cholangitis Therapeutics Market Size 2016-2021 (Million US$)
Table North America Key Players Primary Biliary Cholangitis Therapeutics Revenue (2020-2021) (Million US$)
Table North America Key Players Primary Biliary Cholangitis Therapeutics Market Share (2020-2021)
Table North America Primary Biliary Cholangitis Therapeutics Market Size by Type 2016-2021 (Million US$)
Table North America Primary Biliary Cholangitis Therapeutics Market Share by Type 2016-2021
Table North America Primary Biliary Cholangitis Therapeutics Market Size by Application 2016-2021 (Million US$)
Table North America Primary Biliary Cholangitis Therapeutics Market Share by Application 2016-2021
Figure Europe Primary Biliary Cholangitis Therapeutics Market Size 2016-2021 (Million US$)
Table Europe Key Players Primary Biliary Cholangitis Therapeutics Revenue (2020-2021) (Million US$)
Table Europe Key Players Primary Biliary Cholangitis Therapeutics Market Share (2020-2021)
Table Europe Primary Biliary Cholangitis Therapeutics Market Size by Type 2016-2021 (Million US$)
Table Europe Primary Biliary Cholangitis Therapeutics Market Share by Type 2016-2021
Table Europe Primary Biliary Cholangitis Therapeutics Market Size by Application 2016-2021 (Million US$)
Table Europe Primary Biliary Cholangitis Therapeutics Market Share by Application 2016-2021
Figure China Primary Biliary Cholangitis Therapeutics Market Size 2016-2021 (Million US$)
Table China Key Players Primary Biliary Cholangitis Therapeutics Revenue (2020-2021) (Million US$)
Table China Key Players Primary Biliary Cholangitis Therapeutics Market Share (2020-2021)
Table China Primary Biliary Cholangitis Therapeutics Market Size by Type 2016-2021 (Million US$)
Table China Primary Biliary Cholangitis Therapeutics Market Share by Type 2016-2021
Table China Primary Biliary Cholangitis Therapeutics Market Size by Application 2016-2021 (Million US$)
Table China Primary Biliary Cholangitis Therapeutics Market Share by Application 2016-2021
Figure Japan Primary Biliary Cholangitis Therapeutics Market Size 2016-2021 (Million US$)
Table Japan Key Players Primary Biliary Cholangitis Therapeutics Revenue (2020-2021) (Million US$)
Table Japan Key Players Primary Biliary Cholangitis Therapeutics Market Share (2020-2021)
Table Japan Primary Biliary Cholangitis Therapeutics Market Size by Type 2016-2021 (Million US$)
Table Japan Primary Biliary Cholangitis Therapeutics Market Share by Type 2016-2021
Table Japan Primary Biliary Cholangitis Therapeutics Market Size by Application 2016-2021 (Million US$)
Table Japan Primary Biliary Cholangitis Therapeutics Market Share by Application 2016-2021
Figure Southeast Asia Primary Biliary Cholangitis Therapeutics Market Size 2016-2021 (Million US$)
Table Southeast Asia Key Players Primary Biliary Cholangitis Therapeutics Revenue (2020-2021) (Million US$)
Table Southeast Asia Key Players Primary Biliary Cholangitis Therapeutics Market Share (2020-2021)
Table Southeast Asia Primary Biliary Cholangitis Therapeutics Market Size by Type 2016-2021 (Million US$)
Table Southeast Asia Primary Biliary Cholangitis Therapeutics Market Share by Type 2016-2021
Table Southeast Asia Primary Biliary Cholangitis Therapeutics Market Size by Application 2016-2021 (Million US$)
Table Southeast Asia Primary Biliary Cholangitis Therapeutics Market Share by Application 2016-2021
Figure India Primary Biliary Cholangitis Therapeutics Market Size 2016-2021 (Million US$)
Table India Key Players Primary Biliary Cholangitis Therapeutics Revenue (2020-2021) (Million US$)
Table India Key Players Primary Biliary Cholangitis Therapeutics Market Share (2020-2021)
Table India Primary Biliary Cholangitis Therapeutics Market Size by Type 2016-2021 (Million US$)
Table India Primary Biliary Cholangitis Therapeutics Market Share by Type 2016-2021
Table India Primary Biliary Cholangitis Therapeutics Market Size by Application 2016-2021 (Million US$)
Table India Primary Biliary Cholangitis Therapeutics Market Share by Application 2016-2021
Figure Central & South America Primary Biliary Cholangitis Therapeutics Market Size 2016-2021 (Million US$)
Table Central & South America Key Players Primary Biliary Cholangitis Therapeutics Revenue (2020-2021) (Million US$)
Table Central & South America Key Players Primary Biliary Cholangitis Therapeutics Market Share (2020-2021)
Table Central & South America Primary Biliary Cholangitis Therapeutics Market Size by Type 2016-2021 (Million US$)
Table Central & South America Primary Biliary Cholangitis Therapeutics Market Share by Type 2016-2021
Table Central & South America Primary Biliary Cholangitis Therapeutics Market Size by Application 2016-2021 (Million US$)
Table Central & South America Primary Biliary Cholangitis Therapeutics Market Share by Application 2016-2021
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Primary Biliary Cholangitis Therapeutics Business 2016-2021 (Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Primary Biliary Cholangitis Therapeutics Business (2016-2021)
Table Abbott Laboratories Recent Development
Table Allergan Plc Company Details
Table Allergan Plc Revenue in Primary Biliary Cholangitis Therapeutics Business 2016-2021 (Million US$)
Figure Allergan Plc Revenue Growth Rate in Primary Biliary Cholangitis Therapeutics Business (2016-2021)
Table Allergan Plc Recent Development
Table Eli Lilly and Co. Company Details
Table Eli Lilly and Co. Revenue in Primary Biliary Cholangitis Therapeutics Business 2016-2021 (Million US$)
Figure Eli Lilly and Co. Revenue Growth Rate in Primary Biliary Cholangitis Therapeutics Business (2016-2021)
Table Eli Lilly and Co. Recent Development
Table Intercept Pharmaceuticals Inc. Company Details
Table Intercept Pharmaceuticals Inc. Revenue in Primary Biliary Cholangitis Therapeutics Business 2016-2021 (Million US$)
Figure Intercept Pharmaceuticals Inc. Revenue Growth Rate in Primary Biliary Cholangitis Therapeutics Business (2016-2021)
Table Intercept Pharmaceuticals Inc. Recent Development
Table Takeda Pharmaceutical Co. Ltd. Company Details
Table Takeda Pharmaceutical Co. Ltd. Revenue in Primary Biliary Cholangitis Therapeutics Business 2016-2021 (Million US$)
Figure Takeda Pharmaceutical Co. Ltd. Revenue Growth Rate in Primary Biliary Cholangitis Therapeutics Business (2016-2021)
Table Takeda Pharmaceutical Co. Ltd. Recent Development
Table Global Primary Biliary Cholangitis Therapeutics Market Size by Regions (Million US$) 2021-2027
Figure Global Primary Biliary Cholangitis Therapeutics Market Size Share by Regions (2021-2027)
Figure Global Primary Biliary Cholangitis Therapeutics Market Size Share by Regions in 2027
Figure North America Primary Biliary Cholangitis Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure Europe Primary Biliary Cholangitis Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure China Primary Biliary Cholangitis Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure Japan Primary Biliary Cholangitis Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure Southeast Asia Primary Biliary Cholangitis Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure India Primary Biliary Cholangitis Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure Central & South America Primary Biliary Cholangitis Therapeutics Market Size Forecast (2021-2027)(Million USD)
Table Global Primary Biliary Cholangitis Therapeutics Market Size by Product (2021-2027) (Million US$)
Figure Global Primary Biliary Cholangitis Therapeutics Market Size by Product (2021-2027)
Figure Global Primary Biliary Cholangitis Therapeutics Market Size by Product in 2027
Table Global Primary Biliary Cholangitis Therapeutics Market Size by Application (2021-2027) (Million US$)
Figure Global Primary Biliary Cholangitis Therapeutics Market Size by Application (2021-2027)
Figure Global Primary Biliary Cholangitis Therapeutics Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Direct Purchase

Your perfect start with Research Allied

Select a license type that your business needs

Single User License - 2800

Multi User License - 3800

Enterprise User License - 4800

Want to customize this report?

This report can be customized according to your requirements. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase.

Enquiry before buy